Elizabeth T. Masters

Author

Also Known As

E Masters, E. Masters, E.T. Masters, Elisabeth Masters, Elizabeth Masters, Elizabeth T Masters, Elizabeth T. Masters, Elizabeth T. Masters, MS, MPH, Elysee HITAYEZU Masters, Masters E

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Cedars-Sinai Medical Center Jagiellonian University Covance (United States)University of Florida

About

Elizabeth T. Masters is an author at Pfizer (United States) specializing in medicine, health sciences, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	216
2	Health Sciences	4	4	283
3	Public Health	3	3	190
4	Engineering	1	1	118
5	Environmental Health	1	1	45

Elizabeth T. Masters

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer Yi‐Long Wu, Shun Lü, You Lü, Journal of Thoracic Oncology	2018	181
Using natural language processing to identify problem usage of prescription opioids David Carrell, David Cronkite, Roy E. Palmer, International Journal of Medical Informatics Natural Language ProcessingOpioid EpidemicSubstance AbuseSubstance UseEngineering	2015	118
The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States Caroline Schaefer, Rachael Mann, Elizabeth T. Masters, Pain Practice	2015	94
Estimating Individual-Level Exposure to Airborne Polycyclic Aromatic Hydrocarbons throughout the Gestational Period Based on Personal, Indoor, and Outdoor Monitoring Hyunok Choi, Frederica P. Perera, Agnieszka Pac, Environmental Health Perspectives	2008	88
Automated Prediction of Risk for Problem Opioid Use in a Primary Care Setting Timothy R. Hylan, Michael Von Korff, Kathleen Saunders, Journal of Pain Opioid EpidemicSubstance AbusePrimary CareSubstance UseHealth Policy	2015	80
Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration Jody L. Green, Becki Bucher Bartelson, M.C. Le Lait, Drug and Alcohol Dependence	2017	67
The prevalence of problem opioid use in patients receiving chronic opioid therapy Roy E. Palmer, David Carrell, David Cronkite, Pain Nlp MethodsOpioid EpidemicSubstance UsePain MedicineNatural Language Processing	2015	65
Relation between prenatal lipid-soluble micronutrient status, environmental pollutant exposure, and birth outcomes Elizabeth T. Masters, Wiesław Jędrychowski, Rosemary L. Schleicher, American Journal of Clinical Nutrition NutritionEnvironmental Pollutant ExposureEarly Life ExposureMedicineEnvironmental Health	2007	45
OA 05.06 Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer Benjamin Solomon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Journal of Thoracic Oncology MedicinePathologyBronchial NeoplasmMolecular OncologyCancer Treatment	2017	34
Evaluating Guideline‐recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia Rachel Halpern, Sonali N. Shah, Joseph C. Cappelleri, Pain Practice	2015	29

Page 1